Reductions in exercise capacity associated with exercise intolerance augment cardiovascular disease risk and predict mortality in chronic kidney disease. This study utilized cardiopulmonary exercise testing to (a) investigate mechanisms of exercise intolerance; (b) unmask subclinical ca and p and vitamin D abnormalities that may precede cardiovascular disease in chronic kidney disease.
Cardiopulmonary exercise testing will carry out in Stage 3-5 chronic kidney disease patients ; estimated glomerular filtration rate \<60 ml/min/1.73 m2) and biochemistry will be added (Ca P Via D PTH FGF23).
Study Type
OBSERVATIONAL
Enrollment
200
CPET
Nooshin Dalili
Tehran, Iran
Calcium x phosphorus change in stage 3-5
CaxP change
Time frame: 12 MONTHS
CPET score change
Evaluation of CPET score change
Time frame: 12 MONTHS
Renal Function change
GFR change
Time frame: 12 MONTHS
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.